Navigation Links
Abbott Expands XIENCE V(R) USA Trial to Enroll Patients into Landmark Dual Anti-Platelet Therapy (DAPT) Trial
Date:8/13/2009

000 patients in the United States. The primary endpoint of XIENCE V USA is a measure of stent thrombosis every year out to five years, as defined by the Dublin/Academic Research Consortium (ARC). The ARC definition of late stent thrombosis was developed to eliminate variability in the definitions across various drug eluting stent trials.

About the DAPT Trial

The DAPT Trial is an independent, large-scale study in size (20,000+ patients) and scope intended to determine the appropriate duration for dual anti-platelet therapy (the combination of aspirin and a second anti-clotting medication to reduce the risk of blood clots) as well as the safety and effectiveness of DAPT to protect patients from stent thrombosis and major adverse cardiovascular and cerebrovascular events (MACCE) following the implantation of either a drug eluting or bare metal stent.

The DAPT concept was developed by a consortium of eight companies (four major stent manufacturers, including Abbott, and four manufacturers of anti-platelet medications) who came together to address a U.S. Food and Drug Administration (FDA) request for this post-market study. The Harvard Clinical Research Institute (www.hcri.harvard.edu) is responsible for the design, conduct and analysis of the overall study.

About XIENCE V

XIENCE V is used to treat coronary artery disease by propping open a narrowed or blocked artery and releasing the drug, everolimus, in a controlled manner to prevent the artery from becoming blocked again following a stent procedure. XIENCE V is built upon Abbott's market-leading bare metal stent, the MULTI-LINK VISION(R) Coronary Stent System. The VISION platform is designed to facilitate ease of delivery, making it easier for physicians to maneuver the stent and treat the diseased portion of the artery. '/>"/>

SOURCE Abbott
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Abbott HIV Test Demonstrates Earlier Disease Detection
2. Centocor Ortho Biotech Inc. Awarded $1.67 Billion Patent Jury Verdict from Abbott Laboratories
3. Abbott & BioGenex Extend the Technology Co-development and Distribution Agreement for Marketing the Xmatrx(R) Advanced Staining Platform for the Automation of FISH, IHC and ISH Molecular Diagnostic Assays
4. Abbott Named One of the Top 10 Companies for Scientists
5. HUYA Bioscience Announces Strategic Alliance With Abbott on Drug and Biomarker Development Candidates From China
6. Abbott to Present at Barclays Global Healthcare Conference
7. Abbott Employee Giving Sets New Records for Employee Participation and Total Donations
8. Abbott Announces 11 Percent Increase in Quarterly Dividend
9. Abbott Expands Its Growing Medical Device Business With Acquisition of Advanced Medical Optics (AMO)
10. Abbott Announces Earnings Guidance for 2009
11. Webcast Alert: Isis Pharmaceuticals Announces That Abbott Exercised Its Option to Acquire Ibis Biosciences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... Research and Markets ( http://www.researchandmarkets.com/research/4r95kr/clinical ... "Clinical Laboratory, Molecular Diagnostics and Genomic Testing Services ... Europe Version" report to their offering. ... of molecular diagnostics and pharmacogenics hold the promise ... that is moving out of the national and ...
(Date:5/5/2015)... 05, 2015 GEA Pharma Systems, ... as recipients of the INTERPHEX Exhibitor Awards for ... their Portable, Continuous, Miniature and Modular (PCMM) platform. ... footprint, continuous processing equipment, smart control systems and ... powders and inactive ingredients into bulk tablets. ...
(Date:5/4/2015)... May 4, 2015 Tobira Therapeutics, Inc. ... the development and commercialization of novel treatments for ... of its merger with Regado Biosciences, Inc. (NASDAQ: ... closing of the merger, Tobira raised $40 million ... investors and all current Tobira institutional investors, including ...
(Date:5/4/2015)... BROOK, N.Y. , May 4, 2015 /PRNewswire/ ... a $250,000 cooperative research and development agreement (CRADA) ... to advance the development of TRB-N0224 for the ... animals, including dogs and cats.  Traverse Biosciences has ... TRB-N0224 for the treatment and control of periodontal ...
Breaking Biology Technology:European Clinical Laboratory, Molecular Diagnostics and Genomic Testing Services Market 2015-2019 2GEA Pharma Systems, G-CON Manufacturing and Pfizer Consortium Receives Best Technology Innovation Award at INTERPHEX 2015 2GEA Pharma Systems, G-CON Manufacturing and Pfizer Consortium Receives Best Technology Innovation Award at INTERPHEX 2015 3Tobira Therapeutics Completes Financing and Merger with Regado Biosciences 2Tobira Therapeutics Completes Financing and Merger with Regado Biosciences 3Tobira Therapeutics Completes Financing and Merger with Regado Biosciences 4Tobira Therapeutics Completes Financing and Merger with Regado Biosciences 5Tobira Therapeutics Completes Financing and Merger with Regado Biosciences 6Traverse Biosciences Executes Agreement with Aratana Therapeutics to Advance Development of TRB-N0224 for the Treatment and Control of Periodontal Disease in Pets 2Traverse Biosciences Executes Agreement with Aratana Therapeutics to Advance Development of TRB-N0224 for the Treatment and Control of Periodontal Disease in Pets 3Traverse Biosciences Executes Agreement with Aratana Therapeutics to Advance Development of TRB-N0224 for the Treatment and Control of Periodontal Disease in Pets 4
... Wis. - MyWeather LLC has named ... marketing officer. , ,Baird went to Carleton College and ... Wisconsin Governor Martin Schreiber. He has served as vice ... major K-12 technology company; vice president of sales and ...
... most prominent pharmaceutical companies has been purchased, its stock ... in a continued limited presence in Wisconsin, but could ... industry, increase distribution of their drug and has returned ... Corp. , a Massachusetts-based pharmaceutical firm, announced on Thursday ...
... When FedEx/Kinkos needed to dispose of 1,100 used ... a cost of $200,000 to the company and a ... Aidmatrix to essentially recycle the machines by donating them to ... , ,In case you ever wondered about what happened to ...
Cached Biology Technology:Genzyme acquistion of Bone Care approved, significant impact forecast 2Genzyme acquistion of Bone Care approved, significant impact forecast 3Genzyme acquistion of Bone Care approved, significant impact forecast 4Internet charity link has a Wisconsin flavor in CEO Scott McCallum 2Internet charity link has a Wisconsin flavor in CEO Scott McCallum 3
(Date:4/27/2015)... Apr. 27, 2015 NXT-ID, Inc. (NASDAQ: ... company focused on the growing mobile commerce market, announces ... pre-order customers the first week of May, 2015 and ... of May. Gino Pereira , ... for the company as Wocket® enters the consumer market. ...
(Date:4/17/2015)... BURNABY, Canada , April 17, 2015 /PRNewswire/ ... projects, growing security concerns, and technological advancement to ... Arabia until 2020   ... " Saudi Arabia Biometric Systems Market Forecast &  Opportunities, 2020 ", biometric ... is projected to register growth at CAGR ...
(Date:4/10/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/cjk4gb/security ) ... Profiles - NEC" report to their offering. ... continue to supply a range of IT security management ... focus on the development of a Big Data and ... the Asia-Pacific region is a ...
Breaking Biology News(10 mins):Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 2Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 3Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 2Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 3NEC Security Competitive Profile 2015 2
... HEIDELBERG, 25 March 2013 Researchers have used ... are transmitted from animals to humans in two ... Denmark. The results, which are published today in ... of methicillin-resistant Staphylococcus aureus (MRSA), a ...
... poplars and willows are candidate "biofuel crops" from which ... content fuels can be efficiently extracted. Domesticating these ... and genetics of trees, and scientists are turning to ... peach and a poplar may not be obvious at ...
... August 2011, researchers from the U.S. Department of Agriculture ... puzzle in Kennewick, Wash. Since Kennewick lies within a ... apple-growing region, an annual survey of fruit trees is ... to look for any invading insects. This time the ...
Cached Biology News:Sequencing tracks animal-to-human transmission of bacterial pathogens 2Peach genome offers insights into breeding strategies for biofuels crops 2Genetic analysis saves major apple-producing region of Washington state 2
Ubiquitin Related I Sampler Kit 10 mu g each...
DNA Repair Sampler Kit 10g each...
PKC Sampler Kit 10 mu g each...
... phase reagent for Virus ... & unique water insoluble ... detergents and chaotropes; Engineered ... non-envelop viruses while preserving ...
Biology Products: